BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+45.36%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$22.7B
AUM Growth
+$22.7B
Cap. Flow
-$175M
Cap. Flow %
-0.77%
Top 10 Hldgs %
85.22%
Holding
124
New
14
Increased
20
Reduced
17
Closed
10

Top Buys

1
MYOK
MyoKardia, Inc. Common Stock
MYOK
$134M
2
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$93M
3
NVTA
Invitae Corporation
NVTA
$83.3M
4
ADCT icon
ADC Therapeutics
ADCT
$79M
5
ADAP
Adaptimmune Therapeutics
ADAP
$29.9M

Top Sells

1
SGEN
Seagen Inc. Common Stock
SGEN
$474M
2
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
$101M
3
TCDA
Tricida, Inc. Common Stock
TCDA
$51.6M
4
NBIX icon
Neurocrine Biosciences
NBIX
$40.7M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$22.8M

Sector Composition

1 Healthcare 97.75%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
OYST
101
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$2.06M 0.01%
+71,428
New +$2.06M
LPTX icon
102
Leap Therapeutics
LPTX
$12M
$2.05M 0.01%
978,454
– –
BLCM
103
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.85M 0.01%
249,123
– –
MTNB icon
104
Matinas BioPharma
MTNB
$10.1M
$1.62M 0.01%
2,096,375
-1,657,846
-44% -$1.28M
GLMD icon
105
Galmed Pharmaceuticals
GLMD
$7.07M
$1.03M ﹤0.01%
215,594
– –
AFMD
106
DELISTED
Affimed
AFMD
$923K ﹤0.01%
200,000
– –
INFI
107
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$525K ﹤0.01%
580,400
– –
MRKR icon
108
Marker Therapeutics
MRKR
$11.2M
$498K ﹤0.01%
240,505
-1,229,693
-84% -$2.55M
ADMS
109
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$442K ﹤0.01%
172,630
– –
GNFT
110
Genfit
GNFT
$198M
$156K ﹤0.01%
28,396
+1,700
+6% +$9.34K
VIRX
111
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$147K ﹤0.01%
556,665
– –
REPL icon
112
Replimune Group
REPL
$460M
$128K ﹤0.01%
+5,141
New +$128K
BDSI
113
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-1,638,334
Closed -$6.21M
RARX
114
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-2,093,839
Closed -$101M
HARP
115
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– –
-204,467
Closed -$2.37M
GTHX
116
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-88,026
Closed -$970K
VYNE icon
117
VYNE Therapeutics
VYNE
$8.09M
– –
-625,345
Closed -$1.68M
URGN icon
118
UroGen Pharma
URGN
$896M
– –
-672,912
Closed -$12M
TPST icon
119
Tempest Therapeutics
TPST
$46.6M
– –
-833,333
Closed -$4.4M
NERV icon
120
Minerva Neurosciences
NERV
$16.8M
– –
-688,531
Closed -$4.15M
IDYA icon
121
IDEAYA Biosciences
IDYA
$2.26B
– –
-126,611
Closed -$522K
CTMX icon
122
CytomX Therapeutics
CTMX
$350M
– –
-20,000
Closed -$153K
1 2 3 4
5